Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 22,000	$ 25,554
General and administrative	12,866	9,790
Total operating expenses	34,866	35,344
Loss from operations	(34,866)	(35,344)
Other income:
Other income and interest income, net	2,772	345
Net loss and net loss attributable to common stockholders	$ (32,094)	$ (34,999)
Net loss per share attributable to common stockholders, basic	$ (0.53)	$ (0.61)
Net loss per share attributable to common stockholders, diluted	$ (0.53)	$ (0.61)
Weighted average common shares outstanding, basic	60,230,077	56,996,495
Weighted average common shares outstanding, diluted	60,230,077	56,996,495
Comprehensive loss:
Net loss	$ (32,094)	$ (34,999)
Other comprehensive loss:
Unrealized gains on marketable securities	117	0
Comprehensive loss	$ (31,977)	$ (34,999)